Dr. Wayne D Hey , DO
Urology • Fort Worth, TX
4809 Brentwood Stair Rd
Fort Worth, TX 76103
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on October 2, 2007; this date does not establish years in practice.
-
Published CMS data list 4,704 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 81000 — Manual urinalysis test with examination using microscope, non-automated: 1,018 service units.
- 87798 — Detection test by nucleic acid for organism, amplified probe technique: 884 service units.
- 87150 — Identification of organisms by genetic analysis, amplified probe technique: 548 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 35 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 3,887 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 893 prescription fills, including refills.
- Finasteride — 393 prescription fills, including refills.
- Amoxicillin-Clavulanate Potass (Amoxicillin/Potassium Clav) — 225 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 40 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 70% of clinicians listed under Urology in Fort Worth, TX (2024, 31 clinicians with data). Median for this group: 2,142. Middle half: 816 to 4,990.
More Medicare Part B services than 75% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: 1,751. Middle half: 623 to 4,690.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 3,810 in 2020 to 4,704 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
4809 Brentwood Stair Rd
Fort Worth, TX 76103
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Philadelphia College Of Osteopathic Medicine
2005
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
496 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $297,427 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $238,686 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
7,372 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$925,748 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $2,670.79 across 89 records.
By nature of payment
- Food and Beverage: $2,670.79 across 89 records.
Reporting-company totals (3 largest of 25)
- Janssen Pharmaceuticals, Inc: $808.48 across 20 records.
- Procept Biorobotics Corporation: $318.05 across 5 records.
- Endo USA, Inc.: $228.97 across 10 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
21 years (graduated 2005)
CMS Doctors and Clinicians data list 2005 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2007
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Hey has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Hey as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Fort Worth and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 70% of clinicians listed under Urology in Fort Worth, TX (2024, 31 clinicians with data). Median for this group: 2,142. Middle half: 816 to 4,990.
More Medicare Part B services than 75% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: 1,751. Middle half: 623 to 4,690.
Medicare-allowed amount
A higher Medicare-allowed amount than 70% of clinicians listed under Urology in Fort Worth, TX (2024, 31 clinicians with data). Median for this group: $156,849. Middle half: $56,254 to $299,523.
A higher Medicare-allowed amount than 80% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: $130,907. Middle half: $56,287 to $242,595.
Paid by Medicare
A higher Medicare payment amount than 80% of clinicians listed under Urology in Fort Worth, TX (2024, 31 clinicians with data). Median for this group: $113,773. Middle half: $41,096 to $227,053.
A higher Medicare payment amount than 80% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: $98,400. Middle half: $41,252 to $185,944.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Urology in Fort Worth, TX (2024, 33 clinicians with data). Median for this group: 1,018. Middle half: 341 to 1,579.
More Part D prescriptions than 90% of clinicians listed under Urology in Texas (2024, 667 clinicians with data). Median for this group: 1,254. Middle half: 393 to 2,342.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Urology in Fort Worth, TX (2024, 33 clinicians with data). Median for this group: $90,696. Middle half: $47,722 to $230,200.
A higher Part D drug cost than 90% of clinicians listed under Urology in Texas (2024, 667 clinicians with data). Median for this group: $146,128. Middle half: $29,835 to $354,962.
43 active clinicians are listed under Urology with a practice address in Fort Worth, TX (961 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Fort Worth
39.5% of these 43 clinicians have the CMS telehealth indicator.
76.7% of these 43 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 23% from 3,810 in 2020 to 4,704 in 2024.
- 2020: 3,810
- 2021: 3,197
- 2022: 3,193
- 2023: 4,822.3
- 2024: 4,704
-
Medicare-allowed amount
Medicare-allowed amount increased 30% from $228,606 in 2020 to $297,427 in 2024.
- 2020: $228,606
- 2021: $213,618
- 2022: $222,636
- 2023: $291,509
- 2024: $297,427
-
Paid by Medicare
Paid by Medicare increased 42% from $168,529 in 2020 to $238,686 in 2024.
- 2020: $168,529
- 2021: $161,177
- 2022: $164,986
- 2023: $230,018
- 2024: $238,686
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 14% from 3,399 in 2020 to 3,887 in 2024.
- 2020: 3,399
- 2021: 3,418
- 2022: 3,429
- 2023: 3,500
- 2024: 3,887
-
30-day fills
30-day fills increased 33% from 5,549 in 2020 to 7,372 in 2024.
- 2020: 5,549
- 2021: 5,699
- 2022: 5,992
- 2023: 6,259
- 2024: 7,372
-
Part D drug cost
Part D drug cost increased 65% from $559,591 in 2020 to $925,748 in 2024.
- 2020: $559,591
- 2021: $942,865
- 2022: $705,435
- 2023: $619,417
- 2024: $925,748
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 136% from $1,131.84 in 2021 to $2,670.79 in 2025.
- 2021: $1,131.84
- 2022: $1,666.96
- 2023: $1,875.02
- 2024: $2,652.43
- 2025: $2,670.79
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 89 records totaling $2,670.79.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Medtronic, Inc. |
Food and Beverage
In-kind items and services
|
INTERSTIM | General | $200.77 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
RYBREVANT | General | $147.22 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
RYBREVANT | General | $146.91 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
RYBREVANT | General | $137.61 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
RYBREVANT | General | $129.65 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
JELMYTO | General | $120.60 |
| Procept Biorobotics Corporation |
Food and Beverage
Cash or cash equivalent
|
AQUABEAM ROBOTIC SYSTEM | General | $103.66 |
| Procept Biorobotics Corporation |
Food and Beverage
Cash or cash equivalent
|
AQUABEAM ROBOTIC SYSTEM | General | $75.78 |
| Procept Biorobotics Corporation |
Food and Beverage
Cash or cash equivalent
|
AQUABEAM ROBOTIC SYSTEM | General | $75.02 |
| Procept Biorobotics Corporation |
Food and Beverage
Cash or cash equivalent
|
AQUABEAM ROBOTIC SYSTEM | General | $40.01 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $34.35 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $33.17 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $31.74 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
JELMYTO | General | $31.66 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $29.30 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $28.65 |
| CIVCO Medical Instruments |
Food and Beverage
Cash or cash equivalent
|
— | General | $27.19 |
| ConvaTec Inc. |
Food and Beverage
In-kind items and services
|
— | General | $27.08 |
| Laborie Medical Technologies Corp. |
Food and Beverage
Cash or cash equivalent
|
Optilume BPH Drug Coated Balloon Catheter | General | $26.91 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $26.43 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $25.62 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $25.21 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $25.13 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $24.82 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $24.72 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
81000
Manual urinalysis test with examination using microscope, non-automated
|
1,018 | 394 | $15.00 | $3.93 |
|
87798
Detection test by nucleic acid for organism, amplified probe technique
|
884 | 50 | $69.23 | $34.39 |
|
87150
Identification of organisms by genetic analysis, amplified probe technique
|
548 | 50 | $75.55 | $34.39 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
495 | 251 | $250.20 | $132.45 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
353 | 212 | $217.99 | $87.94 |
|
J1580
Injection, garamycin, gentamicin, up to 80 mg
|
144 | 123 | $40.00 | $2.49 |
|
J1885
Injection, ketorolac tromethamine, per 15 mg
|
112 | 89 | $38.93 | $0.66 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
102 | 93 | $401.96 | $247.73 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
85 | 85 | $330.00 | $173.25 |
|
87500
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique
|
69 | 50 | $200.00 | $34.39 |
|
87640
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
|
69 | 50 | $200.00 | $34.39 |
|
87653
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique
|
69 | 50 | $200.00 | $34.39 |
|
51741
Electronic assessment of bladder emptying
|
67 | 66 | $150.00 | $8.21 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
65 | 65 | $45.00 | $11.72 |
|
76856
Complete ultrasound scan of pelvis
|
62 | 60 | $201.66 | $73.00 |
|
76770
Complete ultrasound scan behind abdominal cavity
|
57 | 56 | $249.12 | $112.20 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
55 | 52 | $248.82 | $179.43 |
|
74485
Review by radiologist of ureter or urethra image
|
41 | 36 | $80.00 | $40.23 |
|
51610
Injection procedure through bladder and urethra for x-ray imaging
|
39 | 36 | $198.72 | $33.23 |
|
51728
Complex measurement of pressure of urine flow in bladder with voiding pressure studies
|
39 | 38 | $594.87 | $377.80 |
|
51784
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings
|
39 | 38 | $489.74 | $33.52 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
39 | 37 | $250.00 | $135.02 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
35 | 23 | $148.77 | $58.32 |
|
51729
Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies
|
21 | 21 | $600.00 | $398.35 |
|
51792
Assessment of muscle signal of pelvic nerves
|
21 | 21 | $500.00 | $142.27 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 893 | 63,087 | $11,247.68 | 293 |
| Finasteride | Finasteride | 393 | 30,483 | $4,629.63 | 116 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 225 | 4,580 | $5,007.33 | 134 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 177 | 2,266 | $1,904.64 | 138 |
| Dutasteride | Dutasteride | 171 | 13,001 | $6,744.94 | 51 |
| Myrbetriq | Mirabegron | 164 | 9,235 | $140,259.81 | 45 |
| Gemtesa | Vibegron | 153 | 8,798 | $141,191.39 | 47 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 151 | 5,439 | $9,852.90 | 66 |
| Cephalexin | Cephalexin | 139 | 3,397 | $1,780.08 | 98 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 133 | 10,036 | $3,516.76 | 40 |
| Testosterone Cypionate | Testosterone Cypionate | 129 | 6,610 | $7,342.13 | 43 |
| Solifenacin Succinate | Solifenacin Succinate | 113 | 6,219 | $7,349.17 | 29 |
| Bethanechol Chloride | Bethanechol Chloride | 83 | 4,071 | $3,829.71 | 22 |
| Desmopressin Acetate | Desmopressin Acetate | 80 | 3,851 | $3,691.26 | 21 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 69 | 483 | $545.20 | 53 |
| Levofloxacin | Levofloxacin | 66 | 959 | $240.64 | 50 |
| Anastrozole | Anastrozole | 66 | 5,553 | $207.32 | 23 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 61 | 3,386 | $1,315.76 | 17 |
| Fluconazole | Fluconazole | 53 | 481 | $337.77 | 33 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 51 | 1,004 | $469.42 | 37 |
| Oxybutynin Chloride | Oxybutynin Chloride | 46 | 2,069 | $1,231.69 | 14 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 40 | 1,903 | $2,557.68 | 20 |
| Methenamine Hippurate | Methenamine Hippurate | 39 | 2,725 | $4,693.77 | 16 |
| Doxazosin Mesylate | Doxazosin Mesylate | 37 | 2,580 | $306.53 | 12 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 35 | 938 | $747.34 | 24 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20111102000295
TX
1557534856
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 4809 BRENTWOOD STAIR RD, FORT WORTH, TX 76103 (Tel: 8177310316)
NPI status registered as active in NPPES database
Registered at 4809 BRENTWOOD STAIR RD, FORT WORTH, TX 761031737 (Tel: 8177310316)
Registered at 4809 BRENTWOOD STAIR RD, FORT WORTH, TX 761031737 (Tel: 8177310316)
Recorded as WAYNE HEY, D.O.
Urology (license number reported to NPPES: TX N9713)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Urology Specialists in Fort Worth
- Dr. Michael Waters, DO
- Dr. Parth Shah, MD
- Dr. Erin Bird, MD
- Dr. Scott Thurman, MD
- Dr. David Gould, MD
- Zain Hyder
Mailing Address
4809 Brentwood Stair Rd
Fort Worth, TX 761031737
Phone: 8177310316